Neurodegeneration Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurodegeneration stocks.

Neurodegeneration Stocks Recent News

Date Stock Title
Jul 3 ANVS Annovis stock swells after Phase III Parkinson’s subgroup success
Jul 3 ANVS Annovis Bio shares dip on phase III Parkinson's trial data
Jul 3 ANVS Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
Jul 3 ANVS Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Jul 2 ANVS Annovis doubles as lead drug improves Parkinson’s
Jul 2 ANVS Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
Jul 1 NRBO NRBO: DA-1726 Shows Superiority to Survodutide in Pre-Clinical Models…
Jul 1 NRSN NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
Jun 30 ANVS Annovis: Strong Sell Reiteration Prior To Phase 3 Data In Parkinson's Disease
Jun 28 DNLI Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
Jun 28 ANVS Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Jun 27 ANVS CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
Jun 27 ANVS Annovis Bio files patent for new manufacturing process of buntanetap
Jun 27 ANVS Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
Jun 27 NRBO NeuroBo doses first subject in Part 2 of Phase I obesity treatment trial
Neurodegeneration

Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Browse All Tags